have been recently reported [3,4] , several aspects of the proper management of these patients are not clear [5,6] . In this editorial some basic principles for the appropriate management of patients with decreased serum sodium levels are briefly summarized.1) It should be stressed that non hypotonic hyponatremia (with normal or increased Posm) should be carefully excluded by a meticulous medical history and the appropriate laboratory investigation. Consequently, the initial approach to the hyponatremic patient includes the determination of Posm (by an osmometer if it is available) as well as the exclusion of pseudohyponatremia (due to severe hypercholesterolemia, hypertriglyceridemia, and hyperproteinemia) or hypertonic hyponatremia [due to the presence of osmotic active agents, such as glucose (hyperglycemia) or the administration of mannitol or glycine] [2,7,8] . It is worth mentioning that in hyperglycemic individuals the corrected serum sodium levels should be calculated by increasing the measured serum sodium levels by 2.4 mEq/L for each 100mg/dl of glucose above normal [4,8] .2) A growing list of drugs, including thiazides, ecstacy and SSRIs, can cause hyponatremia, while endocrine causes of hyponatremia (mainly adrenal insufficiency) should be carefully and appropriately assessed [9,10] .3) Urine sodium in a random urine specimen is commonly used to differentiate between hypovolemia-induced hyponatremia (urine sodium <20 mEq/L) and the syndrome of inappropriate antidiuresis (SIADH, urine sodium >30 mEq/L). However, increased urine sodium levels (>30 mEq/L) can also be encountered in patients with extracellular volume contraction with renal or adrenal insufficiency, severe metabolic alkalosis, osmotic diuresis, as well as in those on thiazides [2,8] .4) In cases of hypovolemia-associated hyponatremia, 0.9% sodium chloride solution should be administered (with potassium chloride 10% if hypokalemia is also present). In this setting potassium anions should be taken into account in the calculation of the tonicity of the infused solutions. Interestingly, the infusate formula proposed by the Adrogue-Madias and verified by Liamis et al can reliably project the effect of gaining 1L of any infusate on the patient's serum sodium (ΔΝα + s) and thus can be used to calculate the rate of the administered 0.9% NaCl solution [2,11,12] .
ABSTRACTHyponatremia due to different pathogenetic mechanisms is the most common electrolyte abnormality and is associated with increased morbidity and mortality. However, several aspects of the proper management of these patients are not clear. In this editorial a brief overview of the basic principles for the appropriate treatment of hyponatremia are summarized.
EDITORIALHyponatremia (serum sodium <135mEq/L) is the most common electrolyte abnormality, is due to different pathophysiologic mechanisms, is associated with increased morbidity and mortality and its appropriate treatment is still a therapeutic challenge [1,2] . Even though clinical practice guidelines on the treatment of hyp...